Trial intelligence / Profile preview

Adjunctive Topiramate in Obsessive-Compulsive Disorder

NCT00187928Phase 3Completed

Sponsor
University of Florida
Start
Jan 2003
Primary completion
Mar 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of topiramate in obsessive compulsive disorder (OCD), sponsored by University of Florida. Started Jan 2003; status: completed.

02

Drugs

topiramate
03

Conditions

obsessive compulsive disorder (OCD)

Beyond the preview

Go deeper on NCT00187928.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00187928.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call